Search
Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.
Researchers are looking for ways to make cancer cells more visible to the immune system.
Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
Immune cells called neutrophils are the first responders to sites of infection. A new study probes what gets them there.
At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Learn about what DNA repair looks like under a microscope.
An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group.
Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.